Erratum: Cocaine detection in maternal and neonatal hair: Implications to fetal toxicology: Expression of concern (Therapeutic Drug Monitoring (2007) 29 (71-76) DOI: 10.1097/ftd.0b013e3180310ddd);Cocaine detection in maternal and neonatal hair: Implications to fetal toxicology

Therapeutic Drug Monitoring

Volumn 29, Issue 1, 2007, Pages 71-76

  Garcia Bournissen, Facundo ^a   Rokach, Ben ^a   Karaskov, Tatyana ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cocaine; Hair detection; Intrauterine exposure; Placental transfer

Indexed keywords

BENZOYLECGONINE; COCAINE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); DOSE RESPONSE; FEMALE; HAIR ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MECONIUM; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; TOXICOLOGY;

EID: 33847145071     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000511     Document Type: Erratum

References (45)

1. Greenblatt JC, Gfroerer JC, Melnick D. Increasing morbidity and mortality associated with abuse of methamphetamine - United States, 1991-1994. MMWR Morb Mortal Wkly Rep. 1995;44:882-886.
2. Banken JA. Drug abuse trends among youth in the United States. Ann N Y Acad Sci. 2004;1025:465-471.
3. Dickerson TJ, Janda KD. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS J. 2005;7:E579-E586.
4. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int. 2002;128:20-30.
5. Koren G, Chan D, Klein J, et al. Estimation of fetal exposure to drugs of abuse, environmental tobacco smoke, and ethanol. Ther Drug Monit. 2002;24:23-25.
6. Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 2001;107:309-317.
7. Kuczkowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anaesth. 2004;51:145-154.
8. Ostrea EM Jr, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr. 2001;138:344-348.
9. Marques PR, Tippetts AS, Branch DG. Cocaine in the hair of mother-infant pairs: quantitative analysis and correlations with urine measures and self-report. Am J Drug Alcohol Abuse. 1993;19:159-175.
10. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med. 1993;328:66-67.
11. Bar-Oz B, Klein J, Karaskov T, et al. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed. 2003;88:F98-F100.
12. Kintz P, Kieffer I, Messer J, et al. Nicotine analysis in neonates' hair for measuring gestational exposure to tobacco. J Forensic Sci. 1993;38:119-123.
13. Graham K, Koren G, Klein J, et al. Determination of gestational cocaine exposure by hair analysis. JAMA. 1989;262:3328-3330.
14. Uematsu T, Yamada K, Matsuno H, et al. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol. Ther Drug Monit. 1991;13:183-187.
15. Kintz P, Tracqui A, Mangin P. [Tobacco, drug and narcotic abuse during pregnancy. Evaluation of in utero exposure by analysis of hair of the neonate.] Presse Med. 1992;21:2139-2141.
16. Akiyama M, Matsuo I, Shimizu H. Formation of cornified cell envelope in human hair follicle development. Br J Dermatol. 2002;146:968-976.
17. Bandstra ES, Morrow CE, Anthony JC, et al. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure. Pediatrics. 2001;108:1309-1319.
18. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159:824-834.
19. Bingol N, Fuchs M, Diaz V, et al. Teratogenicity of cocaine in humans. J Pediatr. 1987;110:93-96.
20. Chavez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1989;262:795-798.
21. Chiriboga CA, Bateman DA, Brust JC, et al. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr Neurol. 1993;9:115-119.
22. Frank DA, Bauchner H, Parker S, et al. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. J Pediatr. 1990;117:622-626.
23. Frank DA, Augustyn M, Knight WG, et al. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA. 2001;285:1613-1625.
24. Koren G, Graham K, Shear H, et al. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet. 1989;2:1440-1442.
25. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: the meaning of subtle effects. Science. 1998;282:633-634.
26. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse - the Canadian experience. Forensic Sci Int. 2000;107:281-288.
27. Klein J, Chan D, Koren G. Neonatal hair analysis as a biomarker for in utero alcohol exposure [Letter]. N Engl J Med. 2002;347:2086.
28. Richardson GA, Day NL. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol Teratol. 1991;13:455-460.
29. Ganapathy V, Leibach FH. Human placenta: a direct target for cocaine action. Placenta. 1994;15:785-795.
30. Pastrakuljic A, Derewlany LO, Knie B, et al. The effects of cocaine and nicotine on amino acid transport across the human placental cotyledon perfused in vitro. J Pharmacol Exp Ther. 2000;294:141-146.
31. Zhou M, Song ZM, Lidow MS. Pharmacokinetics of cocaine in maternal and fetal rhesus monkeys at mid-gestation. J Pharmacol Exp Ther. 2001;297:556-562.
32. Pastrakuljic A, Derewlany LO, Koren G. Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta. 1999;20:499-512.
33. Morishima HO, Okutomi T, Whittington RA, et al. Dose-related differences in the distribution of cocaine in the maternal-fetoplacental compartments in rats. Neurotoxicol Teratol. 2000;22:837-844.
34. Addis A, Moretti ME, Ahmed SF, et al. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001;15:341-369.
35. Sherwood RA, Keating J, Kavvadia V, et al. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr. 1999;158:488-492.
36. Brown JV, Bakeman R, Coles CD, et al. Maternal drug use during pregnancy: are preterm and full-term infants affected differently? Dev Psychol. 1998;34:540-554.
37. Held JR, Riggs ML, Dorman C. The effect of prenatal cocaine exposure on neurobehavioral outcome: a meta-analysis. Neurotoxicol Teratol. 1999;21:619-625.
38. Singer L, Arendt R, Farkas K, et al. Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome. Dev Psychopathol. 1997;9:473-489.
39. Kelly RC, Mieczkowski T, Sweeney SA, et al. Hair analysis for drugs of abuse. Hair color and race differentials or systematic differences in drug preferences? Forensic Sci Int. 2000;107:63-86.
40. Marques PR. Factors to consider when using hair as a cocaine-exposure measure for mothers or newborns. NIDA Res Monogr. 1996;166:183-197.
41. Garcia-Bournissen F, Rokach B, Karaskov T, et al. Methamphetamine detection in maternal and neonatal hair; Implications for fetal safety. Arch Dis Child. In press.
42. Pichini S, Puig C, Zuccaro P, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the 'Meconium Project.' Forensic Sci Int. 2005;153:59-65.
43. Bailey B, Morris P, McMartin KI, et al. Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys. Reprod Toxicol. 1998;12:517-523.
44. Simone C, Derewlany LO, Koren G. Cocaine transfer across a cocaine exposed placental cotyledon perfused in vitro. Life Sci. 1995;57:L137-L140.
45. Simone C, Derewlany LO, Oskamp M, et al. Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon. Am J Obstet Gynecol. 1994;170:1404-1410.